Grammarly’s comprehensive writing assistance with generative AI features drives 28x ROI and saves over 19 working days per year per employee for ModMed
SAN FRANCISCO–(BUSINESS WIRE)–#ai—Grammarly, the company helping over 30 million people and 70,000 teams work smarter and faster wherever they write, today announced that ModMed® is increasing its efficiency in communication with Grammarly’s AI writing assistance. As a fast-growing provider of intelligent, specialized healthcare software, ModMed is using Grammarly Business to save time while focusing on strategic initiatives.
Spending less time on day-to-day writing tasks and more time on high-value work helps ModMed push the pace of technological advancement in an industry that’s historically slow to adapt. Grammarly’s AI writing partner has helped ModMed:
“AI will separate businesses that get ahead from those that fall behind—full stop,” said Matt Rosenberg, Grammarly’s Chief Revenue Officer and Head of Grammarly Business. “We’re proud to support an innovator like ModMed that’s using AI strategically to enhance agility and adaptability, and in an industry that’s slow to evolve, no less. Grammarly makes it easier for ModMed’s teams to get everyday work done, so they can move more quickly and focus on doing what they do best.”
ModMed experienced year-over-year growth in 2022 as it rapidly delivered new solutions across several medical specialties, and investing in Grammarly Business helped the company improve productivity. ModMed started using Grammarly’s in-line assistance to interact more quickly and consistently by refining writing correctness, clarity, style, and tone. Grammarly enforces ModMed’s style guide, so team members get real-time suggestions on how to write in the company’s tone and style, and they also use preset text snippets for fast, consistent responses.
ModMed CEO Daniel Cane discovered that using an AI writing partner like Grammarly had a positive impact on efficiency in communications. As a result, he expanded the use of Grammarly’s generative AI features for a productivity boost. Over 600 team members use Grammarly for tasks like facilitating brainstorming, quickly polishing chats and emails, and creating first drafts of content to speed up production time. And because Grammarly applies company context, tone, and style preferences to its output and suggestions, ModMed’s team members can work faster and achieve more.
“ModMed uses technology to transform healthcare, and it’s wonderful to have a partner in Grammarly who’s as invested as us in using AI to reshape efficiency,” Cane said. “I couldn’t imagine working without Grammarly. We use its generative AI to help with first drafts, ideation, and designing the framework of our conversations. Then, once we’re done creating, Grammarly’s in-line features ensure everything is clean, concise, and on tone.”
Grammarly works across more than 500,000 apps and websites—more than other AI writing assistants—so ModMed team members get support right where they’re working without having to switch between tools. Grammarly Business also provides advanced analytics and enterprise-grade security, with the most comprehensive security certifications of any AI writing assistance company. The company never sells customer data or lets third parties use it to train their models.
“Grammarly is always there assisting you, whether you’re writing an email, doing research, or completing a deck,” added Adam Scott Riff, Chief Marketing Officer of ModMed. “It helps us be more efficient and increase productivity. It helps free up our team members to focus on the things they really enjoy and to innovate.”
To learn more about how ModMed sets the standard for innovation in the e-health market, visit modmed.com. For more on Grammarly and how its generative AI features are changing how businesses run, visit grammarly.com/business.
Additional Resources:
About Grammarly
Grammarly is the world’s leading AI writing assistance company, trusted by over 30 million people and 70,000 professional teams. From instantly creating a first draft to perfecting every message, Grammarly helps people at 96% of the Fortune 500 get their point across—and get results—without compromising security or privacy. Grammarly’s product offerings—Grammarly Free, Grammarly Premium, Grammarly Business, and Grammarly for Education—work where you do, delivering contextually relevant writing support across over 500,000 apps and websites. Founded in 2009, Grammarly is No. 7 on the Forbes Cloud 100, one of TIME’s 100 Most Influential Companies, one of Fast Company’s Most Innovative Companies in AI, and one of Inc.’s Best Workplaces. Learn more at grammarly.com/about.
About ModMed
ModMed is transforming healthcare by placing doctors and patients at the center of care through an intelligent, specialty-specific cloud platform. With our electronic health records (EHR) and practice management (PM) systems, and our revenue cycle management (RCM) services, our all-in-one solution empowers specialty medical practices by providing clinical, financial and operational software solutions. Our staff physicians help to develop products and services for allergy, dermatology, gastroenterology, OBGYN, ophthalmology, orthopedics, otolaryngology, pain management, plastic surgery, podiatry and urology practices, as well as ambulatory surgery centers. For more information, visit modmed.com. Connect with ModMed via its blog, Facebook, LinkedIn, Twitter and Instagram.
Contacts
Sheridan Smalley
Sheridan.Smalley@grammarly.com
206-948-2606
NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is…
Miami, Florida--(Newsfile Corp. - December 21, 2024) - Amid the vibrant backdrop of Art Basel…
Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…
MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…